AIQ Global (operating as AIQ Solutions) is a Madison, Wisconsin company that builds software medical devices for quantitative analysis of oncology imaging. Its platform reads serial radiographic scans (PET and CT) and measures how individual lesions change over time, so oncologists can see treatment response that whole-body summary measures miss. The technology targets late-stage metastatic disease, where different lesions in the same patient respond differently to the same therapy. The company's lead product is FDA-cleared for clinical use.